| BBB | Blood–brain barrier |
| CaMKII | Calcium/calmodulin-dependent protein kinase II |
| CCI | Chronic constriction injury |
| CNS | Central nervous system |
| CNO | Clozapine-N-oxide |
| CREB | cAMP response element-binding protein |
| DL | Drug-likeness |
| DREADDs | Designer receptors exclusively activated by designer drugs |
| EIC | Extracted ion chromatogram |
| GABA | Gamma-aminobutyric acid |
| GO | Gene Ontology |
| HE | Hematoxylin–eosin staining |
| IPN | Interpeduncular nucleus |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| MHb | Medial habenula |
| mPFC | Medial prefrontal cortex |
| NMDAR | N-methyl-D-aspartate receptor |
| NMDAR-2B | NMDA receptor subunit 2B |
| NPP | Neuropathic pain |
| OB | Oral bioavailability |
| OPA | Ortho-phthalaldehyde |
| RT-qPCR | Quantitative real-time PCR |
| SNI | Spared nerve injury |
| SNRIs | Serotonin–norepinephrine reuptake inhibitors |
| STZYD | Shentong Zhuyu Decoction |
| TCAs | Tricyclic antidepressants |
| TCM | Traditional Chinese medicine |
| TIC | Total ion chromatogram |